STOCK TITAN

Hyperfine (HYPR) DEF 14A Filings

HYPR NASDAQ

Here are the DEF 14A proxy statements from Hyperfine, Inc. (HYPR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow HYPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HYPR filings page.

Rhea-AI Summary

Hyperfine, Inc. calls a virtual-only 2026 annual stockholder meeting on May 21, 2026 at 10:00 a.m. Eastern Time. Stockholders of record as of March 25, 2026 may vote Class A and high‑vote Class B shares via www.virtualshareholdermeeting.com/HYPR2026 using a 16‑digit control number.

Stockholders will elect five directors and vote on ratifying Grant Thornton LLP as independent auditor for the year ending December 31, 2026. Founder Jonathan Rothberg beneficially owns all 15,055,288 Class B shares, giving him majority voting control, so the company qualifies as a Nasdaq “controlled company.”

The proxy describes Hyperfine’s AI‑powered, portable Swoop MRI platform, recent FDA, CE Mark, UKCA and India regulatory clearances, and international expansion efforts. It also details executive and director compensation, equity plans, board committees, and an executive severance plan aligned with change‑in‑control situations.